Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infected elderly patients with underlying disease

Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infected elderly patients with underlying disease - Safety and efficacy of peramivir against influenza virus infected elderly patients with underlying disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020696

Enrollment

Registered

2016-01-23

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza virus infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients 65 years or older who had been hospitalized with influenza treated with peramivir during February-2012 March 2015.

Exclusion criteria

Exclusion criteria: outpatients

Design outcomes

Primary

Measure	Time frame
the time from administration to return to normal temperatures	—

Secondary

Measure	Time frame
mortality, adverse events	—

Countries

Japan

Contacts

Public ContactTakamatsu Kazufumi

Kitano Hospital, The Tazuke Kofukai Medical Research Institute Department of Respiratory medicine

k-takamastu@kitano-hp.or.jp06-6312-1221

Outcome results